Oxford Nanopore Technologies, founded in 2005 and headquartered on the Oxford Science Park, develops and commercializes nanopore-based electronic sensing systems for real-time DNA and RNA sequencing. The company's technology enables single-molecule analysis, a capability applied across scientific research, healthcare, industrial processes, and environmental monitoring. Its platform has been cited in more than 20,000 peer-reviewed publications and is used by customers in over 125 countries.
The product portfolio includes the MinION, a portable pocket-sized sequencing device, and the PromethION, a range of high-throughput benchtop and production-scale systems. These products span a broad technical stack, requiring expertise in nanopore science, molecular biology, electronics, engineering, informatics, and manufacturing.
The company employs over 1,000 people across a global network of offices. Beyond its UK bases in Oxford and Cambridge, it maintains a significant presence in the United States (New York, Cambridge, and San Francisco), as well as operations in Singapore, Shanghai, Beijing, Japan, Germany, France, and India.
